Patents by Inventor Sayoko Kanie

Sayoko Kanie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
    Patent number: 8148427
    Abstract: The benzylamine derivative represented by the formula below and a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutical containing the derivative or the pharmaceutically acceptable acid addition salt thereof, and a therapeutic or prophylactic agent for pollakiuria or urinary incontinence containing the derivative or the pharmaceutically acceptable acid addition salt thereof are provided. The benzylamine derivative of the present invention and the pharmaceutically acceptable acid addition salt thereof have less possibility of occurrence of side effects than known compounds, and show a better therapeutic effect against pollakiuria or urinary incontinence, so that they can be used as excellent therapeutic or prophylactic agents for pollakiuria or urinary incontinence.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: April 3, 2012
    Assignee: Toray Industries, Inc.
    Inventors: Ryoji Hayashi, Tsukasa Kikuchi, Masaki Arai, Satoshi Kurosawa, Ko Hasebe, Sayoko Kanie, Seiichiro Ozono, Atsushi Otsuka
  • Method for therapy of diarrhea-predominant irritable bowel disorders
    Patent number: 8058286
    Abstract: A method for therapy of diarrhea-predominant irritable bowel disorders comprising as an effective ingredient a morphinan derivative having a nitrogen-containing cyclic group or a pharmaceutically acceptable acid addition salt thereof is disclosed. The method for therapy of diarrhea-predominant irritable bowel disorders comprises as an effective ingredient a morphinan derivative or a pharmaceutically acceptable acid addition salt thereof, having a specific structure, such as N-(17-cyclopeopylmethyl-4,5?-epoxy-3,14-dihydroxy-morphinan-6?-yl)-3,4,5,6-tetrahydrophthalimide tartaric acid salt (Compound 10).
    Type: Grant
    Filed: November 7, 2006
    Date of Patent: November 15, 2011
    Assignee: Toray Industries, Inc.
    Inventors: Koji Kawai, Morihiro Fujimura, Sayoko Kanie, Yohei Noro
  • BENZYLAMINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF, AND USE THEREOF FOR MEDICAL PURPOSES
    Publication number: 20100099769
    Abstract: The benzylamine derivative represented by the formula below and a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutical containing the derivative or the pharmaceutically acceptable acid addition salt thereof, and a therapeutic or prophylactic agent for pollakiuria or urinary incontinence containing the derivative or the pharmaceutically acceptable acid addition salt thereof are provided. The benzylamine derivative of the present invention and the pharmaceutically acceptable acid addition salt thereof have less possibility of occurrence of side effects than known compounds, and show a better therapeutic effect against pollakiuria or urinary incontinence, so that they can be used as excellent therapeutic or prophylactic agents for pollakiuria or urinary incontinence.
    Type: Application
    Filed: January 31, 2008
    Publication date: April 22, 2010
    Applicant: TORAY INDUSTRIES, INC.
    Inventors: Ryoji Hayashi, Tsukasa Kikuchi, Masaki Arai, Satoshi Kurosawa, Ko Hasebe, Sayoko Kanie, Seiichiro Ozono, Atsushi Otsuka
  • Therapeutic or Prophylactic Agent for Functional Bowel Disorder
    Publication number: 20090111843
    Abstract: A therapeutic or prophylactic agent for functional bowel disorders comprising as an effective ingredient a morphinan derivative having a nitrogen-containing cyclic group or a pharmaceutically acceptable acid addition salt thereof is disclosed. The therapeutic or prophylactic agent for functional bowel disorders comprises as an effective ingredient a morphinan derivative or a pharmaceutically acceptable acid addition salt thereof, having a specific structure, such as N-(17-cyclopropylmethyl-4,5?-epoxy-3,14-dihydroxy-morphinan-6?-yl)-3,4,5,6-tetrahydrophthalimide tartaric acid salt (Compound 10).
    Type: Application
    Filed: November 7, 2006
    Publication date: April 30, 2009
    Applicant: TORAY INDUSTRIES, INC.
    Inventors: Koji Kawai, Morihiro Fujimura, Sayoko Kanie, Yohei Noro